ORGAN PRESERVATION SOLUTIONS MARKET ANALYSIS

Organ Preservation Solutions MarketSize and Trends

The global organ preservation solutions market is estimated to account for US$ 238.7 Mn in terms of value in 2020 and is expected to reach US$ 695.0 Mn by the end of 2027.

Custodiol HTK held dominant position in the global organ preservation solutions market in 2019, accounting for 51.1% share in terms of value, followed by Viaspan and Perfadex, respectively.

The global organ preservation solutions market was valued at US$ 204.9 Mn in 2019 and is forecast to reach a value of US$ 695.0 Mn by 2027 at a CAGR of 16.5% between 2020 and 2027.

Figure 2. Global Organ Preservation Solutions Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Market Trends/Key Takeaways

The emergence of Covid-19 is expected to have significant impact on heart and lung transplant. For instance, in August 2020, researchers from University Hospital of Siena, Italy, reported that a higher percentage of lung transplant subjected that Covid-19 could have a negative impact on the outcome of their graft. Moreover, 28% of the patients declared that they were afraid to come to the hospital for routine examinations and asked to postpone.

Increasing funding for development and launch of new solutions is expected to propel growth of the global organ preservation solutions market over the forecast period. For instance, in January 2020, UK and Ireland-focused SME investor BGF provided US$ 6.05 million to OrganOxm, a medtech developer, as the company looks to fund commercial expansion of its Metra unit, a fully-automated system for keeping a human donor liver functioning for up to 24 hours outside the body.